Description
Market Analysis and Size
Data Bridge Market Research analyses that the Clinical Microbiology Market which was USD 3.9 billion in 2021, would rocket up to USD 6.53 billion by 2029, and is expected to undergo a CAGR of 6.65% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.Genome sequencing-based assays, characterisation assays, genome sequencing-based assays, and mass spectrometry-based detection are all making significant progress in clinical microbiology. Furthermore, in recent years, laboratory automation and information systems linkage for big data and AI methods have been implemented in the clinical microbiology sector
Clinical Microbiology Market Dynamics
Drivers
· Increased funding and public-private investment
In the forecast period of 2022-2029, the substitution of old empirical approaches in clinical diagnostics to detect infectious pathogens such as virus, fungi, and bacteria is expected to fuel the growth of the clinical microbiology market. Increased funding and public-private investment, on the other hand, will further strengthen numerous opportunities, resulting in the clinical microbiology market's rise over the forecast period.
Opportunities
One of the major factor driving the market's growth is the rising occurrence of infectious diseases around the world. Furthermore, rising air and water pollution levels are leading to an increase in the number of people developing respiratory ailments, which drives the market. Aside from that, the incorporation of automation in clinical microbiology is boosting market growth since it allows for specimen traceability, decreases incubation delays, and increases laboratory efficiency. Furthermore, the major competitors are concentrating on adopting technology improvements in illness diagnostics, such as the use of machine learning (ML), which aids in the delivery of speedy and accurate results. This, together with the emergence of many molecular diagnostic techniques, is presenting the market with lucrative growth potential.
Clinical Microbiology Market Regional Analysis/Insights
The clinical microbiology market is analysed and market size insights and trends are provided by country, product type, application and end-user as referenced above.
The countries covered in the clinical microbiology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Competitive Landscape and Clinical Microbiology Market Share Analysis
Global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to clinical microbiology market.
Some of the major players operating in the clinical microbiology market are:
· BioMérieux (France)
· Danaher (US)
· BD (US)
· Abbott (US)
· F. Hoffmann-La Roche Ltd (Switzerland)
· Thermo Fisher Scientific Inc. (US)
· QIAGEN (Netherlands)
· 3M (US)
· Bio-Rad Laboratories (US)
· Bruker (US)
· Hologic Inc. (US)
· Merck KGaA (Germany)
· Diagnóstica Longwood SL (Chennai)
· Agilent Technologies Inc. (U.S)
· Memmert GmbH + Co.KG (Germany)
· Hardy Diagnostics (U.S)
· NEOGEN Corporation (U.S)
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Reports@
According to research report the clinical microbiology market is expected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018 growing at a CAGR of 6.4% during forecast period.
Growth in clinical microbiology market can be attributed to factors such as rising incidence of infectious diseases and growing outbreak of epidemics and increased funding and public-private investments.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219135367Market Size EstimationA detailed market estimation approach was followed to estimate and validate the size of the clinical microbiology market and other dependent submarkets, as mentioned above.
The key players in the clinical microbiology market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research.
Research methodology includes the study of the annual and quarterly financial reports of the top market players as well as interviews with industry experts for key insights (both quantitative and qualitative trends) on the clinical microbiology market.
All percentage shares, splits, and breakdowns were determined by using secondary sources and verified through primary sources.
The global clinical microbiology market is segmented by product, disease area, end user, and region.
The global clinical microbiology market size is expected to reach USD 6.6 billion by 2028 at a CAGR of 6.7%, according to the latest report by Reports and Data.
The market is expected to gain robust traction in the coming years due to rising prevalence of infectious diseases worldwide, growing need for early and accurate disease diagnosis, and increasing R activities to develop pathogen-specific diagnostic kits.
In addition, growing adoption of advanced genomic techniques for disease detection, increased availability of low-cost clinical microbiology products, and growing use of clinical microbiology products across clinical diagnostic centers and research laboratories are other factors fueling the growth of the global clinical microbiology market.Clinical microbiology is the study of microbes that cause severe infections in the human body.
Clinical microbiology aids in rapid diagnosis of pathogens and ensures effective administration of antibiotics to enhance treatment results.
It uses several advanced diagnostic methods, such as MALDI–TOF mass spectrometry, real-time genome sequencing, and phenotypic microarrays, for sampling and analysis processes.
The global clinical microbiology market growth is further driven by rapid development of the healthcare infrastructure worldwide.Top Companies Profiled in the Report Include: Merck KGaA, BioMérieux, 3M, Becton, Dickinson and Company, Danaher Corporation, Abbott Laboratories, Bruker Corporation, Hologic Inc., Bio-Rad Laboratories Inc., Roche Diagnostics, Thermo Fisher Scientific Inc., QIAGEN, Arrow Diagnostics, Agilent Technologies, Memmert, Hardy Diagnostics, NEOGEN Corporation, Biotechnology Solutions, Liofilchem, Shimadzu Corporation, Rapid Micro Biosystems, TCS Biosciences, New Horizons, OpGen, and Vacutest KimaGet a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4032Market Overview: The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness.
